Background Disparities in type 2 diabetes (T2D) care provision and clinical outcomes have
been reported in the last 2 decades in the UK. Since then, a number of initiatives have …

Aim To describe population‐level time trends in prescribing patterns of type 2 diabetes
therapy, and in short‐term clinical outcomes (glycated haemoglobin [HbA1c], weight, blood …

Aims To measure the variation in prescribing of second‐line non‐insulin diabetes drugs.
Materials and Methods We evaluated time trends for the period 1998 to 2016, using …

Objectives Other than age, diabetes is the largest contributor to overall healthcare costs and
reduced life expectancy in Europe. This paper aims to more exactly quantify the net impact …

Introduction Low-quality communication between patients and care providers and limited
patient knowledge of the disease and the therapy are important factors associated with poor …

Objectives To describe primary care utilisation patterns among adults with type 2 diabetes
and to quantify the association between utilisation and long-term health outcomes. Design …

Background Missing clinical outcome data are a common occurrence in longitudinal studies.
Data quality in clinical audit is a particular cause for concern. The relationship between …

Background and aims The list of available treatment options for managing blood glucose in
patients with type 2 diabetes (T2D) has grown over recent years making the task of choosing …

Aim To investigate temporal changes in glycaemic control and the use of
antihyperglycaemic therapies in females and males with type 2 diabetes from 2013 to 2019 …

The costs of drug prescriptions for diabetes in the NHS Page 1 Correspondence 226 www.thelancet.com
Vol 393 January 19, 2019 undertake scientific research, yet alone give convincing evidence-based …